GUJARAT KIDNEY AND SUPER SPECIALITY
Back to Cashflow Statement
|
GUJARAT KIDNEY AND SUPER SPECIALITY Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹228 Cr | ₹6.16 Cr | ₹-0.47 Cr | - | - |
What is the latest Cash Flow from Financing Activities ratio of GUJARAT KIDNEY AND SUPER SPECIALITY ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹228 Cr |
| Mar2025 | ₹6.16 Cr |
| Mar2024 | ₹-0.47 Cr |
| Mar2023 | - |
| Mar2022 | - |
How is Cash Flow from Financing Activities of GUJARAT KIDNEY AND SUPER SPECIALITY Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹228 Cr | 3,606.60 | |
| Mar2025 | ₹6.16 Cr | Positive | |
| Mar2024 | ₹-0.47 Cr | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | - | |
Compare Cash Flow from Financing Activities of peers of GUJARAT KIDNEY AND SUPER SPECIALITY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT KIDNEY AND SUPER SPECIALITY | ₹1,530.3 Cr | 9% | 19.6% | NA | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹116,696.0 Cr | -8.7% | -7.4% | 6.7% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹91,963.2 Cr | -6.8% | -6.2% | -18.4% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹61,779.8 Cr | -6.7% | -6.5% | 8.6% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹59,332.2 Cr | -5.9% | -13.7% | -18.6% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹35,596.6 Cr | -6.4% | -10.1% | 4.2% | Stock Analytics | |
GUJARAT KIDNEY AND SUPER SPECIALITY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT KIDNEY AND SUPER SPECIALITY | 9% |
19.6% |
|
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses